Search Term: Progressive Retinal Atrophy crd4 (PRA crd4) / cord1
Breeds
Relevance Rating: There is some evidence or research available for these breeds
Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful for these breeds
Disease Name
Progressive Retinal Atrophy crd4 (PRA crd4) / cord1
Disease Name 2
Cone-Rod Dystrophy 4
OMIA
1432
Gene Name
RPGRIP1
Mutation
c.2404_2406del
Mutation 2
ins 44 bp
Mutation 3
g.8228_8229 insA29GGAAGCAACAGGATG
Disease Code
PRA cord1
Test Type
Genetic Disease/Disorder
Details
If eye-tested at or before 10 weeks of age, the appearance may be normal to an opthamologist. Early signs of disease can be detected by an opthamoligist from around 6 months of age. Signs of vision loss in the dog may become noticable by owners from 9 months. The effects of this mutation were initially believed to result in an early onset form of PRA, typically with an age of onset around two years of age, but more recent results show that some dogs with two copies of this mutation are not diagnosed until much later in life, sometimes as late as 10 years of age.
Details 2
The earliest ophthalmoscopic signs, which include changes in the granular appearance of the tapetal fundus followed by generalized tapetal hyperreflectivity and retinal vascular attenuation, are detectable at approximately 6 months of age. The electroretinogram of affected dogs is typically normal in waveform and latency at 10 weeks of age but markedly reduced in amplitude or even virtually extinguished by 9 months. (Mellersh et al., 2006)
Published
Mellersh, CS., Boursnell, ME., Pettitt, L., Ryder, EJ., Holmes, NG., Grafham, D., Forman, OP., Sampson, J., Barnett, KC., Blanton, S., Binns, MM., Vaudin, M. : Canine RPGRIP1 mutation establishes cone-rod dystrophy in miniature longhaired dachshunds as a homologue of human Leber congenital amaurosis. Genomics 88:293-301, 2006. Pubmed reference: 16806805. DOI: 10.1016/j.ygeno.2006.05.004.
Published 2
Kuznetsova, T., Iwabe, S., Boesze-Battaglia, K., Pearce-Kelling, S., Chang-Min, Y., McDaid, K., Miyadera, K., Komaromy, A., Aguirre, G.D. : Exclusion of RPGRIP1 ins44 from Primary Causal Association with Early-Onset Cone-Rod Dystrophy in Dogs. Invest Ophthalmol Vis Sci 53:5486-501, 2012. Pubmed reference: 22807295. DOI: 10.1167/iovs.12-10178.
Published 3
Forman, O.P., R.J. Hitti, M. Boursnell, K. Miyadera, D. Sargan, and C. Mellersh, Canine genome assembly correction facilitates identification of a MAP9 deletion as a potential age of onset modifier for RPGRIP1-associated canine retinal degeneration. Mamm Genome 2016
Body/System/Process
Eye
OMIA Url
Inheritance
AR
Gene Name Text
RPGRIP1
Researched Breeds
Mini-longhaired Dachshund
Breed-specific 1
Dachshunds (any variety)
Breed-specific 1 Details
Original publication (Mellersh et al., 2006) reported strong association between mutation and disease in an inbred colony of MLHDs. Subsequent publications reported variability in phenotype associated with this mutation in outbred MLHDs and in Expert comments: 2016 Forman et al., reported a second mutation, in MAP9, that modifies the effect of the RPGRIP1 insertion. This, and other studies, showed that MLHDs that are homozygous for the RPGRIP1 mutation alone are affected with a late-onset, slowly progressing cone deficit that doesn't necessarily lead to visual impairment, whereas dogs that are homozygous for the RPGRIP1 and MAP9 mutations suffer from an early onset, rapidly progressing disease. In breeds that segregate the MAP9 mutation, avoiding breeding RPGRIP1 homozygotes is rational because it can be associated with a blinding disease. In breeds that don't segregate the MAP9 mutation, breeding away from the RPGRIP1 mutation may simply serve the purpose of eliminating the late onset, slowly progressing disease. The challenge is that screening for the MAP9 mutation is technically very difficult, due to the nature of the mutation. In the absence of information regarding the segregation of MAP9 in a particular breed it seems prudent to breed away from RPGRIP1 in all varieties of Dachshunds. Mellersh, C. S., M. E. Boursnell, L. Pettitt, E. J. Ryder, N. G. Holmes, D. Grafham, O. P. Forman, J. Sampson, K. C. Barnett, S. Blanton, M. M. Binns and M. Vaudin, (2006) Canine RPGRIP1 mutation establishes cone-rod dystrophy in miniature longhaired dachshunds as a homologue of human Leber congenital amaurosis. Genomics, 88, 293-301.; Miyadera, K., K. Kato, J. Aguirre-Hernandez, T. Tokuriki, K. Morimoto, C. Busse, K. Barnett, N. Holmes, H. Ogawa, N. Sasaki, C. S. Mellersh and D. R. Sargan, (2009) Phenotypic variation and genotype-phenotype discordance in canine cone-rod dystrophy with an RPGRIP1 mutation. Mol Vis, 15, 2287-305.
Breed-specific 2
Australian Cobberdog, Australian Labradoodle, Beagle, Boykin Spaniel, Chihuahuas, Continental Toy Spaniel Papillon or Phalene, Curly Coated Retriever, English Springer Spaniel, Field Spaniel, French Bulldog, Irish Glen of Imaal Terrier, Labrador Retriever, Portuguese Podengo/Warren hound, Pug
Breed-specific 2 Details
Original publication (Mellersh et al., 2006) reported strong association between mutation and disease in an inbred colony of MLHDs. Subsequent publications reported variability in phenotype associated with this mutation in outbred MLHDs and in Expert comments: 2016 Forman et al., reported a second mutation, in MAP9, that modifies the effect of the RPGRIP1 insertion. This, and other studies, showed that MLHDs that are homozygous for the RPGRIP1 mutation alone are affected with a late-onset, slowly progressing cone deficit that doesn't necessarily lead to visual impairment, whereas dogs that are homozygous for the RPGRIP1 and MAP9 mutations suffer from an early onset, rapidly progressing disease. In breeds that segregate the MAP9 mutation, avoiding breeding RPGRIP1 homozygotes is rational because it can be associated with a blinding disease. In breeds that don't segregate the MAP9 mutation, breeding away from the RPGRIP1 mutation may simply serve the purpose of eliminating the late onset, slowly progressing disease. The challenge is that screening for the MAP9 mutation is technically very difficult, due to the nature of the mutation. In the absence of information regarding the segregation of MAP9 in a particular breed it seems prudent to breed away from RPGRIP1 in all varieties of Dachshunds. Mellersh, C. S., M. E. Boursnell, L. Pettitt, E. J. Ryder, N. G. Holmes, D. Grafham, O. P. Forman, J. Sampson, K. C. Barnett, S. Blanton, M. M. Binns and M. Vaudin, (2006) Canine RPGRIP1 mutation establishes cone-rod dystrophy in miniature longhaired dachshunds as a homologue of human Leber congenital amaurosis. Genomics, 88, 293-301.; Miyadera, K., K. Kato, J. Aguirre-Hernandez, T. Tokuriki, K. Morimoto, C. Busse, K. Barnett, N. Holmes, H. Ogawa, N. Sasaki, C. S. Mellersh and D. R. Sargan, (2009) Phenotypic variation and genotype-phenotype discordance in canine cone-rod dystrophy with an RPGRIP1 mutation. Mol Vis, 15, 2287-305.
GTPs
Heidelberg, BW
DE
DE
Generatio GmbH Center for Animal Genetics
HGTD Leadership Sponsor Test Discovery- GTP In House Testing Out Sourced Testing
Maribor
SI
SI
EVG Diagnostics
In House Testing ISO Accredited/ GTP Other Recognized Accreditation Out Sourced Testing Participant
Plzen
CZ
CZ
Genomia s.r.o
HGTD Leadership Sponsor In House Testing ISO Accredited/ GTP ISO Accredited/LAB ISO Accredited/tests Participant
St. Kilda, Victoria
AU
AU
Spokane, Washington
US
US
Paw Print Genetics
HGTD Leadership Sponsor Test Discovery- GTP In House Testing Non-participant Other Recognized Accreditation Subsidiary Company
Wageningen
NL
NL
VHL Genetics
HGTD Leadership Sponsor Test Discovery- GTP In House Testing ISO Accredited/ GTP ISO Accredited/LAB Out Sourced Testing Supporter
Naas, Co. Kildare
IE
IE
Weatherbys Scientific
In House Testing ISO Accredited/LAB ISO Accredited/tests Other Recognized Accreditation Out Sourced Testing Supporter
Vancouver, Washington
US
US
Key Comment